ATE518864T1 - Verfahren zur herstellung von carbapenemverbindungen - Google Patents
Verfahren zur herstellung von carbapenemverbindungenInfo
- Publication number
- ATE518864T1 ATE518864T1 AT02775896T AT02775896T ATE518864T1 AT E518864 T1 ATE518864 T1 AT E518864T1 AT 02775896 T AT02775896 T AT 02775896T AT 02775896 T AT02775896 T AT 02775896T AT E518864 T1 ATE518864 T1 AT E518864T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- organic solvents
- pharmaceutically acceptable
- formula
- organic solvent
- Prior art date
Links
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical class C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000003960 organic solvent Substances 0.000 abstract 5
- 239000007787 solid Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000011261 inert gas Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32513001P | 2001-09-26 | 2001-09-26 | |
| PCT/US2002/029879 WO2003027067A2 (en) | 2001-09-26 | 2002-09-20 | Process for making carbapenem compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE518864T1 true ATE518864T1 (de) | 2011-08-15 |
Family
ID=23266556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02775896T ATE518864T1 (de) | 2001-09-26 | 2002-09-20 | Verfahren zur herstellung von carbapenemverbindungen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7022841B2 (de) |
| EP (1) | EP1474426B8 (de) |
| JP (1) | JP4480396B2 (de) |
| KR (1) | KR100628676B1 (de) |
| CN (2) | CN100387599C (de) |
| AT (1) | ATE518864T1 (de) |
| AU (1) | AU2002341747B2 (de) |
| BR (1) | BRPI0212411B8 (de) |
| CA (1) | CA2461565C (de) |
| CY (1) | CY1112092T1 (de) |
| DK (1) | DK1474426T3 (de) |
| EA (1) | EA008168B1 (de) |
| ES (1) | ES2368997T3 (de) |
| HU (1) | HU230700B1 (de) |
| IL (1) | IL160413A0 (de) |
| MX (1) | MXPA04002797A (de) |
| NZ (1) | NZ531174A (de) |
| PL (1) | PL218808B1 (de) |
| PT (1) | PT1474426E (de) |
| RS (1) | RS52410B (de) |
| UA (1) | UA78524C2 (de) |
| WO (1) | WO2003027067A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003026572A2 (en) * | 2001-09-26 | 2003-04-03 | Merck & Co., Inc. | Crystalline forms of ertapenem sodium |
| HUP0402112A2 (hu) * | 2001-11-16 | 2005-02-28 | Ranbaxy Laboratories Limited | Eljárás kristályos imipenem előállítására |
| WO2006059753A1 (en) * | 2004-11-30 | 2006-06-08 | Astellas Pharma Inc. | Novel oral pharmaceutical suspension of cefdinir crystal |
| CN100457760C (zh) * | 2005-10-20 | 2009-02-04 | 上海交通大学 | 尔他培南钠盐的制备方法 |
| WO2008062279A2 (en) * | 2006-11-20 | 2008-05-29 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of carbapenem antibiotic |
| CN101367812B (zh) * | 2007-06-28 | 2011-04-27 | 山东轩竹医药科技有限公司 | 被巯基吡咯烷甲酰胺基环戊烯酸取代的培南衍生物 |
| CN101372490B (zh) * | 2007-08-15 | 2011-02-09 | 山东轩竹医药科技有限公司 | 含有巯基氮杂环乙烯基氮杂环的培南衍生物 |
| EP2303225B1 (de) * | 2008-06-11 | 2013-11-20 | Ranbaxy Laboratories Limited | Zusammensetzungen des Kohlenstoffdioxid Adduktes von Ertapenem und Polymorphe Formen des Mononatriumsalzes von Ertapenem |
| CN102558182B (zh) * | 2010-12-31 | 2015-02-11 | 石药集团中奇制药技术（石家庄）有限公司 | 一种厄他培南钠晶型及其制备方法 |
| CN102363617B (zh) * | 2011-11-09 | 2013-09-18 | 上海希迈医药科技有限公司 | 一种厄他培南单钠盐结晶体及其制备方法 |
| WO2013150550A2 (en) * | 2012-04-04 | 2013-10-10 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of carbapenem antibiotic |
| IN2013MU03862A (de) | 2013-12-11 | 2015-07-31 | Unimark Remedies Ltd | |
| CN113416193B (zh) * | 2021-08-23 | 2021-12-17 | 凯莱英医药集团（天津）股份有限公司 | 厄他培南钠新晶型及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
| IE60588B1 (en) * | 1986-07-30 | 1994-07-27 | Sumitomo Pharma | Carbapenem compound in crystalline form, and its production and use |
| JP3048196B2 (ja) * | 1991-06-20 | 2000-06-05 | 第一製薬株式会社 | カルバペネム誘導体 |
| GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| FI103046B (fi) * | 1992-03-11 | 1999-04-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemij ohdannaisten valmistamiseksi |
| ZA938438B (en) * | 1992-11-17 | 1994-06-20 | Sankyo Co | Crystalline carbapenem derivative |
| KR20000064997A (ko) * | 1996-04-26 | 2000-11-06 | 가와무라 요시부미 | 1-메틸카르바페넴유도체 |
| US6180783B1 (en) * | 1997-06-16 | 2001-01-30 | Merck & Co., Inc. | Stabilized carbapenem intermediates and improved process for carbapenem synthesis |
| US5872250A (en) | 1997-07-30 | 1999-02-16 | Merck & Co., Inc. | Process for synthesizing carbapenem antibiotics |
| CA2322658C (en) * | 1998-03-02 | 2005-04-12 | Merck & Co., Inc. | Process for synthesizing carbapenem antibiotics |
| TWI250160B (en) * | 1999-07-06 | 2006-03-01 | Sankyo Co | Crystalline 1-methylcarbapenem compound |
| AR035728A1 (es) * | 2001-01-16 | 2004-07-07 | Merck & Co Inc | Proceso perfeccionado para la sintesis de carbapenem |
| WO2003026572A2 (en) * | 2001-09-26 | 2003-04-03 | Merck & Co., Inc. | Crystalline forms of ertapenem sodium |
-
2002
- 2002-09-20 WO PCT/US2002/029879 patent/WO2003027067A2/en not_active Ceased
- 2002-09-20 MX MXPA04002797A patent/MXPA04002797A/es active IP Right Grant
- 2002-09-20 PL PL371666A patent/PL218808B1/pl unknown
- 2002-09-20 EA EA200400474A patent/EA008168B1/ru unknown
- 2002-09-20 NZ NZ531174A patent/NZ531174A/en not_active IP Right Cessation
- 2002-09-20 AU AU2002341747A patent/AU2002341747B2/en not_active Expired
- 2002-09-20 CN CNB2006100043356A patent/CN100387599C/zh not_active Expired - Lifetime
- 2002-09-20 IL IL16041302A patent/IL160413A0/xx unknown
- 2002-09-20 US US10/485,134 patent/US7022841B2/en not_active Expired - Lifetime
- 2002-09-20 AT AT02775896T patent/ATE518864T1/de active
- 2002-09-20 ES ES02775896T patent/ES2368997T3/es not_active Expired - Lifetime
- 2002-09-20 HU HU0500329A patent/HU230700B1/hu unknown
- 2002-09-20 BR BRPI0212411A patent/BRPI0212411B8/pt not_active IP Right Cessation
- 2002-09-20 UA UA20040403037A patent/UA78524C2/uk unknown
- 2002-09-20 PT PT02775896T patent/PT1474426E/pt unknown
- 2002-09-20 KR KR1020047004533A patent/KR100628676B1/ko not_active Expired - Lifetime
- 2002-09-20 CN CNB028184319A patent/CN100338064C/zh not_active Expired - Lifetime
- 2002-09-20 DK DK02775896.0T patent/DK1474426T3/da active
- 2002-09-20 CA CA002461565A patent/CA2461565C/en not_active Expired - Lifetime
- 2002-09-20 JP JP2003530658A patent/JP4480396B2/ja not_active Expired - Lifetime
- 2002-09-20 EP EP02775896A patent/EP1474426B8/de not_active Expired - Lifetime
- 2002-09-20 RS YU22404A patent/RS52410B/sr unknown
-
2011
- 2011-10-31 CY CY20111101043T patent/CY1112092T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112092T1 (el) | Διεργασια για την κατασκευη ενωσεων καρβαπενεμης | |
| ATE370131T1 (de) | Verfahren zur herstellung von 5-(1,3-oxazol-2- yl)benzoesäurederivaten | |
| ATE519747T1 (de) | Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten | |
| ATE261966T1 (de) | Wasserfreie mirtazapin-kristalle und ein verfahren zu ihrer herstellung | |
| ATE244263T1 (de) | Verfahren zur herstellung von n-glycyltyrosin | |
| ATE373667T1 (de) | Verfahren zur herstellung von ceftiofur | |
| DE69937988D1 (de) | Verfahren zur herstellung von 3-cephemderivaten | |
| ATE419230T1 (de) | Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin | |
| ATE202350T1 (de) | Verfahren zur herstellung von sulfonylharnstoffderivaten | |
| CA2363875A1 (en) | Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide | |
| ATE363460T1 (de) | Verfahren zur herstellung von fluorhalogenalkanen | |
| ATE228512T1 (de) | Verfahren zur herstellung von 3-isochromanonen durch cyclisierung von o- chlormehtylphenylessigsäuren | |
| NO20002315D0 (no) | Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| ATE189453T1 (de) | Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen | |
| WO2003061552A3 (en) | Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone | |
| DE602004020050D1 (de) | Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte | |
| DE69330658D1 (de) | Verfahren zur Herstellung von 4-substituierten Azetidinonderivaten | |
| DE60142962D1 (de) | Verfahren zur herstellung von pestiziden verbindungen | |
| ATE155132T1 (de) | Verfahren zur herstellung von amino- thiadiazolylacetylhaliden | |
| ATE223377T1 (de) | Verfahren zur herstellung von difluoracetophenon- derivaten | |
| HRP20040264B1 (en) | Process for making carbapenem compounds | |
| ATE321028T1 (de) | Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen | |
| ATE226207T1 (de) | Verfahren zur herstellung von beta-lactam verbindungen | |
| ATE261977T1 (de) | Verfahren zur herstellung von substituerten 9- amino-9,10-dihdropyrrolo(2,1-b)(1, 3)benzothiazepinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1474426 Country of ref document: EP |